Literature DB >> 17619964

Blood interactions with plasticised poly (vinyl chloride): influence of surface modification.

Xiaobin Zhao1, James M Courtney, Hua Q Yin, Robin H West, G D O Lowe.   

Abstract

Surface modification of plasticised poly (vinyl chloride) (PVC), with di-(2-ethylhexyl) phthalate (DEHP) as plasticiser, for the improvement of blood compatibility in potential clinical use such as cardiopulmonary bypass was achieved by heparinisation. The influence of surface modification on blood compatibility was assessed in terms of the influence on fibrinogen and factor XII adsorption in vitro, and the generation of thrombin-antithrombin III complex (TAT) and the complement component C3a, in vitro and ex vivo. Electron spectroscopy for chemical analysis (ESCA) was used to characterise the heparinised surface in order to correlate the surface properties with the blood response. Results indicate that at the plasticised PVC surface there is a higher content of heparin than that of the PVC and the DEHP content is lower than that present at the surface of standard plasticised PVC. The blood compatibility assessment confirms the importance of surface modification for the improvement of blood compatibility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619964     DOI: 10.1007/s10856-007-3191-6

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  16 in total

1.  Antithrombin III regulates complement activity in vitro.

Authors:  J M Weiler; R J Linhardt
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

2.  In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response.

Authors:  N M Lamba; J M Courtney; J D Gaylor; G D Lowe
Journal:  Biomaterials       Date:  2000-01       Impact factor: 12.479

Review 3.  Design of nonthrombogenic polymer surfaces for blood-contacting medical devices.

Authors:  S W Kim; H Jacobs
Journal:  Blood Purif       Date:  1996       Impact factor: 2.614

Review 4.  Blood-contacting biomaterials: bioengineering viewpoints.

Authors:  J M Courtney; N M Lamba; J D Gaylor; C J Ryan; G D Lowe
Journal:  Artif Organs       Date:  1995-08       Impact factor: 3.094

5.  Extracorporeal circulation: in vivo and in vitro analysis of complement activation by heparin-bonded surfaces.

Authors:  M Kirschfink; B Kovacs; K Mottaghy
Journal:  Circ Shock       Date:  1993-07

6.  On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.

Authors:  G Elgue; M Blombäck; P Olsson; J Riesenfeld
Journal:  Thromb Haemost       Date:  1993-08-02       Impact factor: 5.249

7.  A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue.

Authors:  O Larm; R Larsson; P Olsson
Journal:  Biomater Med Devices Artif Organs       Date:  1983

8.  Biocompatibility of cardiopulmonary bypass: influence on blood compatibility of device type, mode of blood flow and duration of application.

Authors:  S Sundaram; J M Courtney; D P Taggart; A C Tweddel; W Martin; A M McQuiston; D J Wheatley; G D Lowe
Journal:  Int J Artif Organs       Date:  1994-02       Impact factor: 1.595

9.  Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial.

Authors:  P Appelgren; U Ransjö; L Bindslev; F Espersen; O Larm
Journal:  Crit Care Med       Date:  1996-09       Impact factor: 7.598

10.  Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.

Authors:  P R Craddock; J Fehr; A P Dalmasso; K L Brighan; H S Jacob
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.